Biblio Discovery — Demo Discovery Service

42 hasil untuk "Per Pfeiffer"

Menampilkan 1–20 · 0,39 detik · RSS

  1. Bab Buku Teks lengkap

    Anti-EGFR Treatment in Patients with Colorectal Cancer

    Camilla Qvortrup; Per Pfeiffer

    Colorectal Cancer - From Prevention to Patient Care · 2012 · Inggris · IntechOpen

  2. Artikel Jurnal

    Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review

    Magnus Ploug; Martin Graversen; Per Pfeiffer dkk.

    BMC Cancer, Vol. 20 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is used in the palliative treatment of peritoneal metastasis. The combination of intraperitoneal and systemic chemotherapy seems rational, and the aim of this systematic review was to compare PIPAC directed monotherapy…

  3. Artikel Jurnal

    Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I–III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol

    Ismail Gögenur; Per Pfeiffer; Tobias Freyberg Justesen dkk.

    BMJ Open, Vol. 13 No. 6 · 2023 · Inggris · DOAJ Scopus

    Introduction Within the last two decades, major advances have been made in the surgical approach for patients with colorectal cancer. However, to this day we face considerable challenges in reducing surgery-related complications and improving long-term oncological outcomes. Unprecedented response…

  4. Artikel Jurnal

    Prevalence and management of immediate drug hypersensitivity observed during antineoplastic drug therapy

    Trine Holm Rasmussen; Charlotte Gotthard Mortz; Per Pfeiffer dkk.

    Acta Oncologica, Vol. 64 · 2025 · Inggris · DOAJ Scopus

    Background: Immediate drug hypersensitivity reactions (IDHRs) complicate the treatment of patients with cancer. Rapid drug desensitization (RDD) is not a standard treatment option in Northern Europe as in Southern Europe and the US. Thus, in Denmark, allergists are not involved when cancer…

  5. Artikel Jurnal

    Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis

    Takayuki Yoshino; Julien Taieb; Yasutoshi Kuboki dkk.

    Therapeutic Advances in Medical Oncology, Vol. 15 · 2023 · Inggris · DOAJ Scopus

    Background: Trifluridine/tipiracil plus bevacizumab (FTD/TPI + BEV) has shown efficacy and tolerability in refractory metastatic colorectal cancer (mCRC). Because randomized controlled trial (RCT) data comparing FTD/TPI + BEV with FTD/TPI are lacking, this meta-analysis evaluated outcomes with both…

  6. Artikel Jurnal

    Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis

    Martin Graversen; Sönke Detlefsen; Jon Kroll Bjerregaard dkk.

    Therapeutic Advances in Medical Oncology, Vol. 10 · 2018 · Inggris · DOAJ Scopus

    Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a laparoscopy-guided administration of aerosolized chemotherapy. PIPAC seems to improve objective tumor response, survival and quality of life in patients with peritoneal metastasis. We assessed feasibility and efficacy of…

  7. Artikel Jurnal Teks lengkap

    Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials

    Mathilde Weisz Ejlsmark; Tine Schytte; Uffe Bernchou dkk.

    Current Oncology, Vol. 30 No. 7 · 2023 · Inggris · DOAJ Scopus

    Pancreatic cancer is rising as one of the leading causes of cancer-related death worldwide. Patients often present with advanced disease, limiting curative treatment options and therefore making management of the disease difficult. Systemic chemotherapy has been an established part of the standard…

  8. Artikel Jurnal Teks lengkap

    High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

    Christina Siesing; Halfdan Sorbye; Anca Dragomir dkk.

    PLOS ONE, Vol. 12 No. 8 · 2017 · Inggris · PLOS Scopus

    Background: High expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate, with prolonged survival in several malignant diseases and with the benefit of platinum-based chemotherapy in ovarian cancer. The aim of this study was to evaluate RBM3 in metastatic colorectal cancer…

    Juga tersedia di: DOAJ

  9. Artikel Jurnal

    A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

    Martina Eriksen; Per Pfeiffer; Kristoffer Staal Rohrberg dkk.

    BMC Cancer, Vol. 22 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Background Patients with BRAF V600E mutated metastatic colorectal cancer (mCRC) have a poor prognosis. The introduction of BRAF targeted therapy with encorafenib and weekly administered cetuximab have shown improved survival with a median progression free survival (PFS) of 4.3 months…

  10. Artikel Jurnal

    A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors

    Rikke Løvendahl Eefsen; Jan Stenvang; Jiri Bartek dkk.

    BMC Cancer, Vol. 26 No. 1 · 2026 · Inggris · DOAJ Scopus

    …levels (DLs) were tested and the MTD was found in DL3: DSF 400 mg once per day (QD) for day 1-7, DSF 200 mg QD day 8-14, Cu 2 mg QD, day 1-15 and vinorelbine (30 mg/m2) day 4 and 11 every third week (Q3W). Conclusion In this phase 1b trial, an MTD for the treatment combination of DSF, Cu and…

  11. Artikel Jurnal

    TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trialResearch in context

    Lene Baeksgaard Jensen; Mette Yilmaz; Marianne Nordsmark dkk.

    EClinicalMedicine, Vol. 70 · 2024 · Inggris · DOAJ Scopus

    Summary: Background: Trifluridine-tipiracil has shown a survival benefit compared with placebo in patients with chemorefractory metastatic esophago-gastric adenocarcinoma. We aimed to compare the efficacy of trifluridine-tipiracil plus bevacizumab vs trifluridine-tipiracil monotherapy in…

  12. Artikel Jurnal

    Prediction of overall survival in patients with locally advanced pancreatic cancer using longitudinal diffusion-weighted MRI

    Anne L. H. Bisgaard; Carsten Brink; Tine Schytte dkk.

    Frontiers in Oncology, Vol. 14 · 2024 · Inggris · DOAJ Scopus

    Background and purposeBiomarkers for prediction of outcome in patients with pancreatic cancer are wanted in order to personalize the treatment. This study investigated the value of longitudinal diffusion-weighted magnetic resonance imaging (DWI) for prediction of overall survival (OS) in patients…

  13. Artikel Jurnal

    Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno­carcinoma after perioperative chemotherapy and radical resection

    Anders Christian Larsen; Susy Shim; Lene Bæksgaard dkk.

    Acta Oncologica, Vol. 65 · 2026 · Inggris · DOAJ Scopus

    Background: Evidence of treatment of patients with relapse following multimodal treatment for oesophageal, gastro-oesophageal junctional and gastric adenocarcinoma is almost absent. Methods: In a nationwide consecutive cohort of 202 patients, radically resected after perioperative chemotherapy…

  14. Artikel Jurnal Teks lengkap

    High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

    Halfdan Sorbye; Anca Dragomir; Magnus Sundström dkk.

    PLOS ONE, Vol. 10 No. 6 · 2015 · Inggris · PLOS Scopus

    RAS and BRAF mutations impact treatment and prognosis of metastatic colorectal cancer patients (mCRC), but the knowledge is based on trial patients usually not representative for the general cancer population. Patient characteristics, treatment and efficacy according to KRAS, BRAF and MSI status…

    Juga tersedia di: DOAJ

  15. Artikel Jurnal

    Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients

    Kristine Ø. Aasebø; Anca Dragomir; Magnus Sundström dkk.

    Cancer Medicine, Vol. 8 No. 7 · 2019 · Inggris · DOAJ Scopus

    Abstract Background Immunotherapy for patients with microsatellite‐instable (MSI‐H) tumors or BRAF‐inhibitors combination treatment for BRAF‐mutated (mutBRAF) tumors in metastatic colorectal cancer (mCRC) is promising, but the frequency of these molecular changes in trial patients are low…